Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
CALL
Fidelity National Information Services
FIS
$22.9B
| $103K | ﹤0.01% |
1,100
+600
| +120% | +$56.4K |
|
5127
CALL
Fabrinet
FN
$19B
| $103K | ﹤0.01% |
3,600
+2,800
| +350% | +$92.6K |
|
|
HSII
5128
DELISTED
Heidrick & Struggles
HSII
| $103K | ﹤0.01% |
4,226
+3,544
| +520% | +$83.1K |
|
5129
Middlesex Water
MSEX
$1.09B
| $103K | ﹤0.01% |
2,576
+1,930
| +299% | +$83.2K |
|
5130
The RMR Group
RMR
$325M
| $103K | ﹤0.01% |
1,731
+1,461
| +541% | +$82.2K |
|
|
ACC
5131
CALL
DELISTED
American Campus Communities, Inc.
ACC
| $103K | ﹤0.01% |
2,500
+1,600
| +178% | +$68.4K |
|
|
ORIT
5132
DELISTED
Oritani Financial Corp. New
ORIT
| $103K | ﹤0.01% |
6,275
+2,654
| +73% | +$44.6K |
|
5133
Griffon
GFF
$4.29B
| $102K | ﹤0.01% |
5,014
+4,240
| +548% | +$92.7K |
|
5134
Gogo Inc
GOGO
$630M
| $102K | ﹤0.01% |
9,044
-5,147
| -36% | -$54.8K |
|
5135
Gorman-Rupp
GRC
$2.26B
| $102K | ﹤0.01% |
3,279
+2,555
| +353% | +$81.1K |
|
5136
PUT
LKQ Corp
LKQ
$6.2B
| $102K | ﹤0.01% |
2,500
+1,000
| +67% | +$38.3K |
|
5137
CALL
Rockwell Medical
RMTI
$29.9M
| $102K | ﹤0.01% |
159
-84
| -35% | -$59.2K |
|
|
SPPI
5138
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $102K | ﹤0.01% |
+5,400
| New | +$97.8K |
|
5139
Horizon Bancorp
HBNC
$1.06B
| $101K | ﹤0.01% |
5,468
+4,349
| +389% | +$80.3K |
|
5140
CALL
Hartford Financial Services
HIG
$38.9B
| $101K | ﹤0.01% |
1,800
-5,000
| -74% | -$279K |
|
5141
Haverty Furniture Companies
HVT
$455M
| $101K | ﹤0.01% |
4,457
+3,056
| +218% | +$73.6K |
|
|
PFC
5142
DELISTED
Premier Financial Corp. Common Stock
PFC
| $101K | ﹤0.01% |
3,872
+3,076
| +386% | +$82.6K |
|
5143
Ares Management
ARES
$32.2B
| $100K | ﹤0.01% |
5,018
+4,769
| +1,915% | +$89.4K |
|
5144
Compañía de Minas Buenaventura
BVN
$8.19B
| $100K | ﹤0.01% |
7,106
-20,599
| -74% | -$285K |
|
5145
CALL
iShares MSCI Australia ETF
EWA
$1.44B
| $100K | ﹤0.01% |
4,300
-13,600
| -76% | -$310K |
|
5146
Geron
GERN
$860M
| $100K | ﹤0.01% |
55,618
-90,058
| -62% | -$182K |
|
5147
CALL
El Pollo Loco
LOCO
$503M
| $100K | ﹤0.01% |
10,100
+500
| +5% | +$5.4K |
|
5148
PUT
PRA Group
PRAA
$672M
| $100K | ﹤0.01% |
3,000
+500
| +20% | +$15.9K |
|
5149
VSE Corp
VSEC
$6.01B
| $100K | ﹤0.01% |
2,089
+1,687
| +420% | +$86.5K |
|
|
ONCT
5150
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $100K | ﹤0.01% |
+56
| New | +$81.1K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.